A chemical probe for BAG1 targets androgen receptor-positive prostate cancer through oxidative stress signaling pathway

BAG1 is a family of polypeptides with a conserved C-terminal BAG domain that functions as a nucleotide exchange factor for the molecular chaperone HSP70. BAG1 proteins also control several signaling processes including proteostasis, apoptosis, and transcription. The largest isoform, BAG1L, controls...

Full description

Saved in:
Bibliographic Details
Published in:iScience 2022-05, Vol.25 (5), p.104175-104175, Article 104175
Main Authors: Kuznik, Nane C., Solozobova, Valeria, Lee, Irene I., Jung, Nicole, Yang, Linxiao, Nienhaus, Karin, Ntim, Emmanuel A., Rottenberg, Jaice T., Muhle-Goll, Claudia, Kumar, Amrish Rajendra, Peravali, Ravindra, Gräßle, Simone, Gourain, Victor, Deville, Célia, Cato, Laura, Neeb, Antje, Dilger, Marco, Cramer von Clausbruch, Christina A., Weiss, Carsten, Kieffer, Bruno, Nienhaus, G. Ulrich, Brown, Myles, Bräse, Stefan, Cato, Andrew C.B.
Format: Article
Language:English
Subjects:
Biochemical engineering
Biochemistry, Molecular Biology
Cancer
Chemistry
Human health and pathology
Life Sciences
Medical biochemistry
Urology and Nephrology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BAG1 is a family of polypeptides with a conserved C-terminal BAG domain that functions as a nucleotide exchange factor for the molecular chaperone HSP70. BAG1 proteins also control several signaling processes including proteostasis, apoptosis, and transcription. The largest isoform, BAG1L, controls the activity of the androgen receptor (AR) and is upregulated in prostate cancer. Here, we show that BAG1L regulates AR dynamics in the nucleus and its ablation attenuates AR target gene expression especially those involved in oxidative stress and metabolism. We show that a small molecule, A4B17, that targets the BAG domain downregulates AR target genes similar to a complete BAG1L knockout and upregulates the expression of oxidative stress-induced genes involved in cell death. Furthermore, A4B17 outperformed the clinically approved antagonist enzalutamide in inhibiting cell proliferation and prostate tumor development in a mouse xenograft model. BAG1 inhibitors therefore offer unique opportunities for antagonizing AR action and prostate cancer growth. [Display omitted] •BAG1L interacts with a sequence overlapping a polyalanine tract in the AR NTD•Knockdown of BAG1L increase AR dynamics in the nucleus•BAG1L uses ROS pathway to regulate AR+ prostate cancer cell proliferation•A small molecule BAG1 inhibitor inhibits prostate tumor growth in mouse xenografts Chemistry; Medical biochemistry; Biochemical engineering; Cancer
ISSN:2589-0042
2589-0042
DOI:10.1016/j.isci.2022.104175